Target intelligence / Profile preview

SPT16 homolog, facilitates chromatin remodeling subunit pseudogene 1 (SUPT16HP1)

Target
SUPT16HP1
Molecular classification
Other (pseudogene)
01

Overview

SUPT16HP1 is a pseudogene related to the SPT16 subunit of the Facilitates Chromatin Transcription (FACT) complex. Pseudogenes are non-coding sequences that resemble functional genes but do not produce active proteins. SUPT16HP1 does not encode an active protein and is not involved in chromatin remodeling or any therapeutic pathway. The functional chromatin remodeling factor is SPT16 (encoded by SUPT16H), which partners with SSRP1 to form the FACT complex—a key regulator of nucleosome dynamics, transcription, and implicated as a therapeutic target in cancer due to its high expression in tumors and essentiality for tumor cell survival[1][3][5]. Summary of core issue: SUPT16HP1 refers to a non-coding pseudogene. The protein-coding parent gene/protein (SPT16, encoded by SUPT16H) is biologically important and pharmacologically relevant, but the pseudogene itself is not a drug target, does not encode an active protein, and should not be considered a therapeutic target[1][3][5].

Other names
bcm670SUPT16HPsuppressor of Ty 16 homolog pseudogene 1
02

Mechanism of action

null

Beyond the preview

Go deeper on SPT16 homolog, facilitates chromatin remodeling subunit pseudogene 1 (SUPT16HP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SPT16 homolog, facilitates chromatin remodeling subunit pseudogene 1 (SUPT16HP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call